Streetbeat News

Revenues

TMDX

TransMedics Group shares declined following the release of disappointing Q3 financial results and FY24 revenue guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:23 pm

EHC

Encompass Health (NYSE:EHC) reported Q3 2024 earnings per share of $1.03, surpassing the analyst estimate of $0.94. The company's sales reached $1.35 billion, exceeding the expected $1.33 billion and marking an 11.93% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:22 pm

FFIV

F5 Networks has provided guidance for Q1 2025, expecting revenue between $705 million and $725 million and adjusted EPS between $3.29 and $3.41.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:21 pm

CALX

Calix (NYSE:CALX) has provided guidance for Q4 with adjusted EPS expected to be between $0.04 and $0.10, compared to the analyst estimate of $0.09. The company anticipates sales to range from $201 million to $207 million.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:20 pm

FFIV

F5 projects a total revenue growth of 4% to 5% and non-GAAP earnings per share growth of 5% to 7% for fiscal year 2025, compared to fiscal year 2024. The midpoint of their non-GAAP EPS guidance indicates a 10% year-over-year growth on a tax-neutral basis.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:19 pm

LEG

Legett & Platt has revised its FY24 revenue guidance to $4.3B-$4.4B from $4.3B-$4.5B, and adjusted EPS to $1.00-$1.10 from $1.10-$1.25, both below previous estimates.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:19 pm

EKSO

Ekso Bionics Holdings reported Q3 EPS of $(0.10), meeting analyst expectations, but sales of $4.13M missed the $5.55M estimate, marking a 10.38% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:19 pm

SKY

Skyline Champion reported Q2 2025 earnings per share of $0.94, surpassing the analyst estimate of $0.81. The company's sales reached $616.90 million, exceeding the expected $602.12 million and marking a 32.88% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:18 pm

CDP

COPT Defense (NYSE:CDP) reported Q3 2024 earnings per share of $0.65, surpassing the analyst estimate of $0.64. The company's sales reached $189.22 million, exceeding the expected $171.43 million and marking a 12.26% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:18 pm

ESI

Element Solutions projects its FY24 adjusted EBITDA to be between $535 million and $540 million, with free cash flow expected to range from $280 million to $300 million.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 8:17 pm